TG Therapeutics, Inc. (TGTX)
53.89
-1.50
(-2.71%)
USD |
NASDAQ |
Sep 11, 16:00
53.87
-0.02
(-0.04%)
After-Hours: 20:00
TG Therapeutics Price to Book Value : 13.66 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 13.66 |
| September 10, 2026 | 14.04 |
| September 09, 2026 | 13.85 |
| September 08, 2026 | 14.12 |
| September 04, 2026 | 14.19 |
| September 03, 2026 | 14.37 |
| September 02, 2026 | 14.42 |
| September 01, 2026 | 14.21 |
| August 31, 2026 | 13.76 |
| August 28, 2026 | 13.67 |
| August 27, 2026 | 14.12 |
| August 26, 2026 | 13.94 |
| August 25, 2026 | 14.04 |
| August 24, 2026 | 14.19 |
| August 21, 2026 | 13.75 |
| August 20, 2026 | 12.81 |
| August 19, 2026 | 13.10 |
| August 18, 2026 | 12.74 |
| August 17, 2026 | 12.49 |
| August 14, 2026 | 12.35 |
| August 13, 2026 | 12.15 |
| August 12, 2026 | 12.54 |
| August 11, 2026 | 12.64 |
| August 10, 2026 | 12.46 |
| August 07, 2026 | 12.61 |
| Date | Value |
|---|---|
| August 06, 2026 | 12.56 |
| August 05, 2026 | 12.64 |
| August 04, 2026 | 12.35 |
| August 03, 2026 | 11.70 |
| July 31, 2026 | 13.18 |
| July 30, 2026 | 13.56 |
| July 29, 2026 | 13.55 |
| July 28, 2026 | 13.90 |
| July 27, 2026 | 14.13 |
| July 24, 2026 | 14.20 |
| July 23, 2026 | 14.06 |
| July 22, 2026 | 13.35 |
| July 21, 2026 | 13.67 |
| July 20, 2026 | 13.67 |
| July 17, 2026 | 13.90 |
| July 16, 2026 | 13.92 |
| July 15, 2026 | 14.29 |
| July 14, 2026 | 13.91 |
| July 13, 2026 | 13.94 |
| July 10, 2026 | 14.47 |
| July 09, 2026 | 14.97 |
| July 08, 2026 | 14.50 |
| July 07, 2026 | 14.71 |
| July 06, 2026 | 14.06 |
| July 02, 2026 | 13.51 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Krystal Biotech, Inc. | 7.556 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| BioMarin Pharmaceutical, Inc. | 2.011 |
| Cytokinetics, Inc. | -- |
| Exelixis, Inc. | 7.576 |
Price to Book Value Related Metrics
| PE Ratio | 19.63 |
| PS Ratio | 10.75 |
| PEG Ratio | 0.031 |
| Price to Free Cash Flow | 494.19 |
| Price | 53.89 |
| Earnings Yield | 5.10% |
| Market Cap | 8.249B |
| PEGY Ratio | 0.031 |
| Operating PE Ratio | 63.02 |
| Normalized PE Ratio | 19.26 |